News
EGTX Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency
Sep 29, 2026 · ThinkSabio Blog
EGTX Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency
29-SEP-2026 05:37 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
